The “liquid biopsy” in non-small cell lung cancer – not quite ready for prime time use

由 Qin, Angel, Ramnath, Nithya
發表在 Transl Cancer Res (2016)

Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?

由 Weinberg, Frank D., Ramnath, Nithya
發表在 Transl Lung Cancer Res (2018)

KRAS-G12C mutation is associated with poor outcome in surgically-resected lung adenocarcinoma

由 Nadal, Ernest, Beer, David, Ramnath, Nithya
發表在 J Thorac Oncol (2015)

Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions

由 Zhang, Zhuo, Ramnath, Nithya, Nagrath, Sunitha
發表在 Front Oncol (2015)

Reactive Oxygen Species in the Tumor Microenvironment: An Overview

由 Weinberg, Frank, Ramnath, Nithya, Nagrath, Deepak
發表在 Cancers (Basel) (2019)

Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches

由 Sankar, Kamya, Nagrath, Sunitha, Ramnath, Nithya
發表在 Cancers (Basel) (2021)

Cigarette Smoking and Gemcitabine-Induced Neutropenia in Advanced Solid Tumors

由 O’Malley, Meaghan, Healy, Patrick, Daignault, Stephanie, Ramnath, Nithya
發表在 Oncology (2013)

Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection

由 Murlidhar, Vasudha, Ramnath, Nithya, Nagrath, Sunitha, Reddy, Rishindra M.
發表在 Cancers (Basel) (2016)

The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?

由 Weinberg, Frank, Dickson, Robert P., Nagrath, Deepak, Ramnath, Nithya
發表在 Cancers (Basel) (2020)

Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer

由 Qin, Angel, Coffey, David G., Warren, Edus H., Ramnath, Nithya
發表在 Cancer Med (2016)

Expanded CTCs from a Patient with ALK Positive Lung Cancer Present EML4-ALK Rearrangement along with Resistance Mutation and Enable Drug Sensitivity Testing: A Case Study

由 Zhang, Zhuo, Shiratsuchi, Hiroe, Palanisamy, Nallasivam, Nagrath, Sunitha, Ramnath, Nithya
發表在 J Thorac Oncol (2016)

Nuclear or cytoplasmic expression of survivin: What is the significance?

由 Li, Fengzhi, Yang, Jie, Ramnath, Nithya, Javle, Milind M., Tan, Dongfeng
出版 2005

Characterization of pneumonia and other factors leading to poorer survival across all age groups in patients with non-small cell lung cancer (NSCLC)

由 Weinberg, Frank D., Zhao, Lili, Chellappa, Niranjana, Kalemkerian, Gregory P., Ramnath, Nithya
發表在 J Thorac Dis (2021)

Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non–Small-Cell Lung Cancer

由 Qin, Angel, Street, Lindsay, Cease, Kemp, Viglianti, Benjamin L., Warren, Edus H., Zhao, Lili, Ramnath, Nithya
發表在 Clin Lung Cancer (2017)

Isolation and profiling of circulating tumor-associated exosomes using extracellular vesicular lipid-protein binding affinity based Microfluidic device

由 Kang, Yoon-Tae, Purcell, Emma, Palacios-Rolston, Colin, Lo, Ting-Wen, Ramnath, Nithya, Jolly, Shruti, Nagrath, Sunitha
發表在 Small (2019)

Simultaneous Single Cell Gene Expression and EGFR Mutation Analysis of Circulating Tumor Cells Reveals Distinct Phenotypes in NSCLC

由 Owen, Sarah, Lo, Ting-Wen, Fouladdel, Shamileh, Zeinali, Mina, Keller, Evan, Azizi, Ebrahim, Ramnath, Nithya, Nagrath, Sunitha
發表在 Adv Biosyst (2020)

Lung Cancer Xenografting Alters MicroRNA Profile but not Immunophenotype

由 Bogner, Paul N., Patnaik, Santosh K., Pitoniak, Rose, Kannisto, Eric, Repasky, Elizabeth, Hylander, Bonnie, Yendamuri, Sai, Ramnath, Nithya
出版 2009

A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)

由 Miller, Antonius A., Pang, Herbert, Hodgson, Lydia, Ramnath, Nithya, Otterson, Gregory A., Kelley, Michael J., Kratzke, Robert A., Vokes, Everett E.
出版 2010

A Radial Flow Microfluidic Device for Ultra-high-throughput Affinity-based Isolation of Circulating Tumor Cells

由 Murlidhar, Vasudha, Zeinali, Mina, Grabauskiene, Svetlana, Ghannad-Rezaie, Mostafa, Wicha, Max S., Simeone, Diane M., Ramnath, Nithya, Reddy, Rishindra M., Nagrath, Sunitha
發表在 Small (2014)

It’s not ‘just a tube of blood’: principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies

由 Jiang, Cindy Y, Niu, Zeqi, Green, Michael D, Zhao, Lili, Raupp, Shelby, Pannecouk, Brittany, Brenner, Dean E, Nagrath, Sunitha, Ramnath, Nithya
發表在 J Immunother Cancer (2021)